Abstract
Vein graft research has increasingly turned to murine models, to exploit the potential of transgenic and knockout mouse lines to study genetically based questions. Several models of murine interpositional vein grafting into arteries have been published, as well as models of vein patch grafting. Models vary on the vein graft source (inferior vena cava, external jugular vein or its distal branches), recipient artery (aorta, carotid, or femoral), and method of engraftment (end-to-end or end-to-side continuous or interrupted suturing or ring-coupling techniques). Outcomes vary considerably, depending on the model employed; neointimal wall thickening is induced that is often comparable to larger vein graft models on an absolute basis, despite the much smaller vessel diameters of mouse vein grafts. Substantial vein graft stenosis is apparently only found with the smaller of these vein graft models. Selecting the appropriate model requires careful consideration of the specific research question to be addressed as well as laboratory expertise with microsurgical techniques.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hess CN, Lopes RD, Gibson CM, et al. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation. 2014;130:1445–51.
Aranki SF, Tatooles AJ. Disconnect between vein graft failure and clinical events after coronary artery bypass graft surgery. Circulation. 2014;130:1439–41.
Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916–31.
Halabi AR, Alexander JH, Shaw LK, et al. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol. 2005;96:1254–9.
Cooley BC. Experimental vein graft research: a critical appraisal of models. Heart Res Open J. 2015;2:53–9. http://dx.doi.org/10.17140/HROJ-2-110
Abbasi K, Shalileh K, Anvari MS, et al. Perivascular nitric oxide delivery to saphenous vein grafts prevents graft stenosis after coronary artery bypass grafting: a novel sheep model. Cardiology. 2011;118:8–15.
Shiroma H, Kusaba A. Ultrastructural features of progressive intimal hyperplasia at the distal end-to-side anastomosis of vein grafts. Cardiovasc Surg. 1996;4:393–8.
Saito T, Iguchi A, Tabayashi K. Irradiation inhibits vascular anastomotic stenosis in a canine model. Gen Thorac Cardiovasc Surg. 2009;57:406–12.
Capecchi MR. The new mouse genetics: altering the genome by gene targeting. Trends Genet. 1989;5:70–6.
Gierut JJ, Jacks TE, Haigis KM. Strategies to achieve conditional gene mutation in mice. Cold Spring Harb Protoc. 2014;4:339–49.
Cooley BC. Murine model of neointimal formation and stenosis in vein grafts. Arterioscler Thromb Vasc Biol. 2004;24:1180–5.
Hu Y, Mayr M, Metzler B, Erdel M, Davison F, Xu Q. Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res. 2002;91:e13–20.
Cooley BC, Nevado J, Mellad J, et al. TGF-β signaling mediates endothelial to mesenchymal transition (EndMT) during vein graft remodeling. Sci Transl Med. 2014;6:227ra234.
Maroney SA, Cooley BC, Ferrel JP, Bonesho CE, Mast AE. Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth. Arterioscler Thromb Vasc Biol. 2011;31:821–6.
Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, Xu Q. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol. 1998;153:1301–10.
Zhang L, Hagen PO, Kisslo J, Peppel K, Freedman NJ. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model. J Vasc Surg. 2002;36:824–32.
Diao Y, Xue J, Segal MS. A novel mouse model of autologous venous graft intimal hyperplasia. J Surg Res. 2005;126:106–13.
Salzberg SP, Filsoufi F, Anyanwu A, von Harbou K, Karlof E, Carpentier A, et al. Increased neointimal formation after surgical vein grafting in a murine model of type 2 diabetes. Circulation. 2006;114:I302–1307.
Greene EC. Anatomy of the rat. Philadelphia: Macmillan Publishing Co.; 1935.
Shi C, Patel A, Zhang D, et al. Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis. Circ Res. 1999;84:883–90.
Sakaguchi T, Asai T, Belov D, et al. Influence of ischemic injury on vein graft remodeling: role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation. J Thorac Cardiovasc Surg. 2005;129:129–37.
Gottlob R. The preservation of the venous endothelium by ‘dissection without touching’ and by an atraumatic technique of vascular anastomosis. The importance for arterial and venous surgery. Minerva Chir. 1977;32:693–700.
Adcock OT, Adcock GL, Wheeler JR, Gregory RT, Snyder SO, Gayle RG. Optimal techniques for harvesting and preparation of reversed autogenous vein grafts for use as arterial substitutes: a review. Surgery. 1984;96:886–94.
Tsui JCS, Souza DSR, Filbey D, Bomfim V, Dashwood MR. Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a ‘no-touch’ technique. Br J Surg. 2001;88:1209–15.
Tennant M, McGeachie JK. Adaptive remodelling of smooth muscle in the neo-intima of vein-to-artery grafts in rats: a detailed morphometric analysis. Anat Embryol. 1993;187:161–6.
Mann MJ, Gibbons GH, Kernoff RS, et al. Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci U S A. 1995;92:4502–6.
Wolff RA, Tomas JJ, Hullett DA, et al. Macrophage depletion reduces monocyte chemotactic protein-1 and transforming growth factor-β1 in healing rat vein grafts. J Vasc Surg. 2004;39:878–88.
Suggs WD, Olson SC, Mandani D, Petal S, Veith FJ. Antisense oligonucleotides to c-fos and c-jun inhibit intimal thickening in a rat vein graft model. Surgery. 1999;126:443–9.
Cooley BC. Differential neointimal response in vein grafts and wire-injured arteries. Circ J. 2007;71:1649–52.
Dilley RJ, McGeachie JK, Tennant M. The role of cell proliferation and migration in the development of a neo-intimal layer in veins grafted into arteries, in rats. Cell Tissue Res. 1992;269:281–7.
Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest. 2004;113:1258–65.
Zhang L, Freedman NJ, Brian L, Peppel K. Graft-extrinsic cells predominate in vein graft arterialization. Arterioscler Thromb Vasc Biol. 2004;24:470–6.
Xu Q, Zhang Z, Davison F, Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res. 2003 Oct 17;93(8):e76-86.
Zhang L, Brian L, Freedman NJ. Vein graft neointimal hyperplasia is exacerbated by CXCR4 signaling in vein graft-extrinsic cells. J Vasc Surg. 2012;56:1390–7.
Hu Y, Xu Q. New mouse model of vein bypass graft atherosclerosis. Heart Lung Circ. 2002;11:182–8.
Liu S, Li Y, Zhang Z, Xie F, et al. α1-Adrenergic receptors mediate combined signals initiated by mechanical stretch stress and norepinephrine leading to accelerated mouse vein graft atherosclerosis. J Vasc Surg. 2013;57:1645–56.
Chen Y, Wong MM, Campagnolo P, et al. Adventitial stem cells in vein grafts display multilineage potential that contributes to neointimal formation. Arterioscler Thromb Vasc Biol. 2013;33:1844–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Cooley, B.C. (2016). Murine Models of Vein Grafting. In: Sata, M. (eds) Mouse Models of Vascular Diseases. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55813-2_7
Download citation
DOI: https://doi.org/10.1007/978-4-431-55813-2_7
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55811-8
Online ISBN: 978-4-431-55813-2
eBook Packages: MedicineMedicine (R0)